Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001091485 | SCV001247559 | pathogenic | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001091485 | SCV001582994 | pathogenic | not provided | 2023-04-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 871488). This premature translational stop signal has been observed in individuals with Stuve-Wiedemann syndrome (PMID: 14740318, 24477277, 25868946). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys253*) in the LIFR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIFR are known to be pathogenic (PMID: 14740318). |
Blueprint Genetics | RCV001091485 | SCV001832361 | pathogenic | not provided | 2019-11-30 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV001809981 | SCV002059481 | pathogenic | Stuve-Wiedemann syndrome | 2019-07-19 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001809981 | SCV002103032 | pathogenic | Stuve-Wiedemann syndrome | 2021-02-10 | criteria provided, single submitter | clinical testing | PVS1, PS4_moderate, PM2 |
Laboratory of Medical Genetics, |
RCV002286811 | SCV002577579 | pathogenic | Stüve-Wiedemann syndrome 1 | 2022-03-02 | criteria provided, single submitter | clinical testing | PVS1, PM2, PP5 |
Institute of Human Genetics Munich, |
RCV002286811 | SCV002764775 | pathogenic | Stüve-Wiedemann syndrome 1 | 2022-06-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001091485 | SCV003837468 | pathogenic | not provided | 2023-03-03 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24477277, 19371797, 25868946, 34958143, 33305909, 14740318) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001809981 | SCV003922864 | pathogenic | Stuve-Wiedemann syndrome | 2023-03-17 | criteria provided, single submitter | clinical testing | Variant summary: LIFR c.756dupT (p.Lys253X), also referred to as c.756_757insT, results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 250744 control chromosomes (gnomAD). c.756dupT has been reported in the literature in multiple homozygous individuals affected with Stuve-Wiedemann Syndrome (e.g. Dangoneau_2004, Corona-Rivera_2009, Buonuomo_2014). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |